Delcath Systems Inc. (DCTH) Sets New 1-Year High at $3.79
Delcath Systems Inc. (NASDAQ:DCTH) shares reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $3.79 and last traded at $3.47, with a volume of 50,945 shares trading hands. The stock had previously closed at $0.26.
The company’s market capitalization is $82.97 million. The stock’s 50-day moving average is $0.26 and its 200-day moving average is $0.31.
Delcath Systems (NASDAQ:DCTH) last issued its quarterly earnings data on Wednesday, May 4th. The medical device company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.19) by $0.11. On average, equities analysts anticipate that Delcath Systems Inc. will post ($0.49) EPS for the current fiscal year.
Delcath Systems, Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS).
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.